{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:41Z","timestamp":1792834721864,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Elevated serum immunoglobulin G4 (IgG4) levels have been reported in various rheumatic diseases; however, the factors associated with IgG4 elevation remain incompletely understood. This study aimed to evaluate the frequency of elevated serum IgG4 in different rheumatic diseases and to explore its association with disease classification based on typical inflammatory characteristics and autoantibody status. This retrospective single-center study included 255 patients with rheumatic diseases who underwent serum IgG4 testing between January 2017 and December 2022. Patients were categorized for exploratory disease-level analyses according to their typical association with elevated C-reactive protein (CRP) levels (rheumatoid arthritis [RA], spondyloarthritis, vasculitis, and adult-onset Still disease) or without prominent CRP elevation (Sj\u00f6gren syndrome, systemic lupus erythematosus, retroperitoneal fibrosis, idiopathic inflammatory myopathy, and undifferentiated connective tissue disease), as well as according to the presence or absence of disease-specific autoantibodies. The frequency of elevated serum IgG4 (\u22651.35\u2009g\/L) was compared between groups. Elevated IgG4 was more frequently observed in patients with RA than in those with Sj\u00f6gren syndrome (30.36% vs 11.83%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.005). Rheumatic diseases classified as CRP-associated demonstrated a higher frequency of elevated IgG4 than non-CRP-associated diseases (30.23% vs 14.20%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Among patients with RA, elevated IgG4 was associated with higher levels of immunoglobulin M, immunoglobulin G, CRP, erythrocyte sedimentation rate, and Disease Activity Score 28-CRP scores (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). In this retrospective cohort, elevated serum IgG4 was more frequently observed in rheumatic diseases classified as CRP-associated than in non-CRP-associated diseases. No significant association was observed between elevated serum IgG4 frequency and autoantibody status. These findings demonstrate an association between disease classification based on typical inflammatory characteristics and the frequency of elevated serum IgG4; however, prospective studies incorporating patient-level inflammatory assessments are required to determine the clinical significance of this association.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050240","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:00:40Z","timestamp":1787968840000},"page":"e50240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with elevated serum IgG4 in rheumatic diseases"],"prefix":"10.1097","volume":"105","author":[{"given":"Juhua","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Peking University International Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Peking University International Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Suining Central Hospital, Suining, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8871-0861","authenticated-orcid":false,"given":"Lianjie","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/CM9.0000000000001891","article-title":"Update on classification, diagnosis, and management of immunoglobulin G4-related disease.","volume":"135","author":"Chen","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"R2-20261024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease.","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R3-20261024","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/s10165-011-0532-6","article-title":"Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases.","volume":"22","author":"Yamamoto","year":"2012","journal-title":"Mod Rheumatol"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"602809","DOI":"10.1155\/2012\/602809","article-title":"Pathologies associated with serum IgG4 elevation.","volume":"2012","author":"Ebbo","year":"2012","journal-title":"Int J Rheumatol"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"e1707","DOI":"10.1097\/MD.0000000000001707","article-title":"Diagnostic performance of serum IgG4 levels in patients with IgG4-related disease.","volume":"94","author":"Yu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody.","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"R7-20261024","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1515\/cclm-2014-1186","article-title":"Immunoglobulin IgA, IgD, IgG, IgM and IgG subclass reference values in adults.","volume":"53","author":"Puissant-Lubrano","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"R8-20261024","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease.","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"787422","DOI":"10.3389\/fimmu.2021.787422","article-title":"The role of IgG4 in autoimmunity and rheumatic diseases.","volume":"12","author":"Maslinska","year":"2021","journal-title":"Front Immunol"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.3748\/wjg.14.4992","article-title":"Diagnostic criteria for autoimmune pancreatitis in Japan.","volume":"14","author":"Kamisawa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"R12-20261024","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R13-20261024","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort.","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R15-20261024","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection.","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R16-20261024","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease.","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"R17-20261024","doi-asserted-by":"crossref","first-page":"232960","DOI":"10.1155\/2012\/232960","article-title":"Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice.","volume":"2012","author":"Ryu","year":"2012","journal-title":"Int J Rheumatol"},{"key":"R18-20261024","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cca.2020.04.001","article-title":"Clinical utility of serum IgG4 measurement.","volume":"506","author":"Varghese","year":"2020","journal-title":"Clin Chim Acta"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R20-20261024","doi-asserted-by":"crossref","first-page":"635293","DOI":"10.1155\/2014\/635293","article-title":"Elevated serum IgG4 defines specific clinical phenotype of rheumatoid arthritis.","volume":"2014","author":"Chen","year":"2014","journal-title":"Mediators Inflamm"},{"key":"R21-20261024","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/biomedicines10030558","article-title":"Frequency and clinical significance of elevated IgG4 in rheumatoid arthritis: a systematic review.","volume":"10","author":"Sakthiswary","year":"2022","journal-title":"Biomedicines"},{"key":"R22-20261024","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/acr.22216","article-title":"Elevated IgG4 serum levels among primary Sj\u00f6gren\u2019s syndrome patients: do they unmask underlying IgG4-related disease?","volume":"66","author":"Mavragani","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:00:38Z","timestamp":1792832438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050240"}},"subtitle":["A retrospective single-center observational study"],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":22,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050240","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2025-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}